Franco Antonio B Felizarta MD
HIV/AIDS Medicine
solo private practice
Join to view full profile
3535 San Dimas StreetSuite 24Bakersfield, CA 93311
Phone+1 661-324-3128
Fax+1 661-324-1129
Dr. Felizarta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Infectious Disease, 1995 - 1997- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1992 - 1995
University of the Philippines College of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2027
NJ State Medical License 1996 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014, 2017
Clinical Trials
- DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy
- QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
Publications & Presentations
PubMed
- Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV...Ezequiel Córdova, Charlotte-Paige Rolle, Kai Hove, Franco Felizarta, Marc Johnson
Open Forum Infectious Diseases. 2026-09-01 - 13 citationsBudigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.Moti N Ramgopal, Jacob P Lalezari, Ana Gabriela Pires Dos Santos, Preethi Krishnan, Tanaya R Vaidya
Nature Medicine. 2025-11-01 - 6 citationsThigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study.Susan L Ford, Franco Felizarta, Kelong Han, Kehui Wang, Herta Crauwels
Clinical Infectious Diseases. 2025-08-01
Press Mentions
Fast Vaccine Rollout Sought to Fight DeltaJuly 21st, 2021
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Tagalog
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: